Skip to search formSkip to main contentSkip to account menu

Oxybutynin chloride 5 MG Oral Tablet

Known as: OXYBUTYNIN CHLORIDE 5 mg ORAL TABLET [Oxybutynin Chloride], OXYBUTYNIN CL 5MG TAB [VA Product], OXYBUTYNIN CHLORIDE 5MG TAB UD 
National Institutes of Health

Related topics

Related topics

21 relations

Broader (2)

ANTISPASMODICS,URINARYoxybutynin
Aluminum OxideBrilliant blue FCFCALCIUM STEARATEDrug Allergy
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Transdermal oxybutynin in the treatment of adults with overactive bladder: combined results of two randomized clinical trials
The safety and efficacy of oxybutynin transdermal delivery system (oxybutynin-TDS) versus placebo in adults with urge and mixed… 
2005
2005
In vivo demonstration of muscarinic receptor binding activity of N-desethyl-oxybutynin, active metabolite of oxybutynin.
2005
2005
267Parenteral oxybutynin: A local anaesthetic effect on bladder C-afferents
2004
2004
Demonstration of bladder selective muscarinic receptor binding by intravesical oxybutynin to treat overactive bladder.
PURPOSE The current study was done to elucidate the in vivo mechanism of action of intravesical instillation of oxybutynin to… 
Highly Cited
2003
Highly Cited
2003
Intravesical oxybutynin: a local anesthetic effect on bladder C afferents.
PURPOSE Intravesical oxybutynin is used to control bladder overactivity in patients who are refractory to or cannot tolerate… 
Highly Cited
2002
Highly Cited
2002
Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence.
Highly Cited
2001
Highly Cited
2001
Side‐effects of oral or intravesical oxybutynin chloride in children with spina bifida
Objective To evaluate the incidence of side‐effects of oral and intravesical oxybutynin chloride in children with… 
Highly Cited
1998
Highly Cited
1998
Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism.
Highly Cited
1997
Highly Cited
1997
Comparison of oxybutynin and its active metabolite, N-desethyl-oxybutynin, in the human detrusor and parotid gland.
Highly Cited
1992
Highly Cited
1992
Measurement of oxybutynin and its N-desethyl metabolite in plasma, and its application to pharmacokinetic studies in young, elderly and frail elderly volunteers.
1. A quantitative h.p.l.c. plasma assay for oxybutynin (OB) and its active metabolite, N-desethyl oxybutynin (DEOB) is described… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License